Codiak BioSciences, Inc.
CDAKDelisted May 2, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001659352
Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Codiak BioSciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 40 | −7 |
| Shares | 17.4M | 237.9K | 14.6M | −2.62M (−15.2%) |
| Value | $13.6M | $186.0K | $5.76M | −$7.66M (−57.1%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Codiak BioSciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 52,402 | $21.0K | 0.00% |
| Citadel Advisors LLC | 32,948 | $13.1K | 0.00% |
| Two Sigma Investments, LP | 29,453 | $11.7K | 0.00% |
| Two Sigma Advisers, LP | 13,600 | $5.41K | 0.00% |
| Belpointe Asset Management LLC | 2,506 | $996 | 0.00% |
| Simplex Trading, LLC | 152 | $0 | 0.00% |
Sold out (13)
Institutions that held Codiak BioSciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Armistice Capital, LLC | 1,000,000 | $782.0K |
| Alaska Permanent Fund Corp | 980,194 | $767.0K |
| Boxer Capital, LLC | 488,157 | $382.0K |
| Trellus Management Company, LLC | 64,582 | $51.0K |
| State of Wisconsin Investment Board | 38,209 | $30.0K |
| Ergoteles LLC | 38,019 | $30.0K |
| Bank of New York Mellon Corp | 18,046 | $14.0K |
| Man Group plc | 15,198 | $12.0K |
| Warberg Asset Management LLC | 10,000 | $8.00K |
| Qube Research & Technologies Ltd | 10,421 | $8.00K |
| Denali Advisors LLC | 9,100 | $7.00K |
| Royal Bank of Canada | 148 | $0 |
| China Universal Asset Management Co., Ltd. | 213 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Codiak BioSciences, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Empery Asset Management, LP | 237,943 | $186.0K |